Arcosa, Inc. current report, 09 May 2023

Arcosa, Inc. Form 8-K Summary

Business Context and Reporting Period

Arcosa, Inc. filed this Form 8-K regarding events occurring on May 9, 2023. The filing covers executive retention awards and the results of the 2023 Annual Meeting of Shareholders. It is not a quarterly or annual financial results filing.

Executive Retention Grants

  • The Human Resources Committee approved one-time retention grants to Chief Financial Officer Gail M. Peck and Group President Reid S. Essl.
  • Each executive received 21,985 time-based restricted stock units with a stated grant-day value of $1.5 million.
  • Vesting occurs over four years: 25% on the second anniversary, 25% on the third anniversary, and 50% on the fourth anniversary of the grant.
  • The grants are intended to support retention and continued leadership efforts.

Annual Meeting Voting Results

ProposalResult
Election of 10 directorsAll nominees were elected to terms expiring at the 2024 annual meeting.
Advisory approval of named executive officer compensationApproved.
Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2023Ratified.

Director votes included 2,567,942 broker non-votes for each nominee. Steven J. Demetriou received the highest number of “Against” votes among the nominees, with 3,562,811.

Financial Metrics, Liquidity, and Debt

The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating financial metrics.

Material Changes, Outlook, and Risks

The principal disclosed change is the issuance of the one-time retention awards, which will create compensation expense and potential share dilution over the vesting period; the filing text does not quantify the accounting expense or dilution impact. The filing provides no management outlook, specific risks, contingencies, or unusual operating items.

Investor Verification Items

  • Verify the accounting treatment, expense recognition, and dilution associated with the 43,970 restricted stock units.
  • Review the proxy statement dated March 28, 2023 for the approved executive compensation details.
  • Confirm the vesting conditions and any forfeiture provisions applicable to the retention grants.
  • Review subsequent filings for changes in executive roles, equity awards, or director composition.